Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AEterna Zentaris Inc (NASDAQ:AEZS)

1.18
Delayed Data
As of May 26
 +0.22 / +22.92%
Today’s Change
0.78
Today|||52-Week Range
5.59
-67.22%
Year-to-Date

Today’s Trading

Previous close0.96
Today’s open0.97
Day’s range0.95 - 1.21
Volume2,853,396
Average volume (3 months)360,263
Market cap$16.3M
Dividend yield--
Data as of 3:59pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)+86.71%
Earnings growth (this year)+42.53%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+67.16%
P/E ratio--
Price/Sales42.25
Price/Book2.45

Competitors

 Today’s
change
Today’s
% change
ABACAoxin Tianli Group I...+0.02+0.94%
OPGNOpGen Inc-0.05-6.50%
BASIBioanalytical System...-0.01-0.61%
PRTOProteon Therapeutics...-0.05-3.85%
Data as of 3:59pm ET, 05/26/2017

Financials

Next reporting dateAugust 15, 2017
EPS forecast (this quarter)-$0.39
Annual revenue (last year)$911.0K
Annual profit (last year)-$25.0M
Net profit margin-2,739.74%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
David A. Dodd
Chief Accounting Officer &
Vice President-Finance
Geneviève Lemaire
Corporate headquarters
Montréal, Qubec

Forecasts